Digital Noema Telehealth and Lumeon Partner to Optimize Telemedicine Pathways - Gilde Healthcare

Digital Noema Telehealth and Lumeon Partner to Optimize Telemedicine Pathways

20 februari 2017

LONDON AND NEW YORK – Today at HIMSS, Lumeon, a leading digital health company, and Digital Noema Telehealth (DN Telehealth), a provider of telemedicine and remote patient monitoring, announce they are partnering to optimize care pathways for telemedicine reimbursements.

DN Telehealth maximizes collaboration compatibility for its clients and their patients, in real-time, extending consultations beyond a physical clinical setting to include fully secure, web browser-based conferencing sessions.  The solution allows clinicians, caregivers and patients to extend care coordination to go beyond traditional care models, to optimize care and promote patient engagement of any “at risk” patient population, in a fully HIPAA-compliant environment.

Lumeon’s Care Pathway Manager seamlessly integrates clinical and administrative systems, and gives providers the ability to design and automate their own pathway rules, so that each patient is automatically progressed through their personal care journey based on their individual data.

“We’ve been looking for a care pathway automation partner for quite some time,” said Roque Espinal-Valdez, founder, and CEO of DN Telehealth. “With Lumeon’s functionality to automate and orchestrate the care pathway, previously manual tasks are eliminated and we can ensure that reimbursable elements are consistently used to deliver predictable outcomes for our customers in the managed care market.”

“Working with DN Telehealth provides us with the opportunity to address one of the fastest growing sectors within healthcare,” said Robbie Hughes, Lumeon CEO. “At the same time, our platform will enable customers of DN Telehealth to automate and orchestrate their care pathways to maximize reimbursement and improve efficiency of care delivery.”

The solution is available in North American and European markets from March 2017.

Gilde Healthcare company Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing

Shoulder Innovations, a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from...
10 maart 2025

Gilde Healthcare announces successful sale of health-it software company Performation to Enovation, part of Legrand

Exit confirms Gilde Healthcare's investment strategy of building market-leading healthcare companies that deliver better care at lower cost Under ownership of Gilde Healthcare’s private equity fund, Performation has evolved into a leading European SaaS healthcare...
13 februari 2025

Gilde Healthcare company NIZO participates in national consortium investing in precision fermentation scale-up facility

The Netherlands is strengthening its position as a global leader in cellular agriculture with the launch of two independent, open-access scale-up facilities. These facilities, developed in a collaboration between NIZO Food Research, Cultivate at Scale...
4 februari 2025